Navigation Links
BioAmber Announces CFO Transition
Date:3/31/2017

MONTREAL, March 31, 2017 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA) announced today that the Company has entered into a mutual separation agreement with Mario Saucier, in connection with his departure from his role of Chief Financial Officer effective March 28, 2017.

BioAmber intends to initiate a search for a replacement CFO and until such time, Raymond J. Land, the current Chairman of the Board, has been appointed as the company's interim Chief Financial Officer effective March 28, 2017. Mr. Land has served on BioAmber's Board since 2011. Prior to his retirement, Mr. Land served as Sr. VP and CFO of Clarient, Inc., a cancer diagnostics company, Sr. VP and CFO of Safeguard Scientifics, Inc., a venture capital firm, and Sr. VP and CFO for Genencor International Inc., from 1997 until its acquisition in 2005. Mr. Land has also held various positions at Campbell Soup Company Inc. and at Coopers & Lybrand, an accounting firm. – See more at: http://investor.bio-amber.com/#committees

About BioAmber

BioAmber (NYSE: BIOA) is a renewable materials company. Its innovative technology platform combines biotechnology and catalysis to convert renewable feedstock into building block materials that are used in a wide variety of everyday products including plastics, paints, textiles, food additives and personal care products.  For more information visit www.bio-amber.com

Forward-Looking Statements

This press release contains forward-looking statements, which are subject to substantial risks, uncertainties and assumptions. All statements other than statements of historical fact contained in this press release are forward-looking statements, including our plans for our search for a full-time CFO. These statements often include words such as "believe," "expect," "anticipate," "intend," "plan," "estimate," "seek," "will," "may" or similar expressions. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond BioAmber's control. BioAmber's actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors. 

Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, it cannot guarantee that the events and circumstances reflected in the forward-looking statements will be achieved or occur and the timing of events and circumstances and actual results could differ materially from those projected in the forward-looking statements. Accordingly, you should not place undue reliance on these forward-looking statements. All such statements speak only as of the date made, and the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise. For additional disclosure regarding these and other risks faced by BioAmber, see disclosures contained in BioAmber's public filings with the SEC including, the "Risk Factors" section of BioAmber's most recent Annual Report on Form 10-K.


'/>"/>
SOURCE BioAmber Inc.
Copyright©2017 PR Newswire.
All rights reserved


Related biology technology :

1. BioAmber announces exercise in full of underwriters option in connection with previously priced follow-on offering
2. BioAmber Begins Commissioning of Sarnia Commercial Plant
3. BioAmber Secures Best-In-Class Technology for Planned BDO/THF Plants
4. BioAmber Announces Webcast of Fiscal First Quarter 2015 Financial Results
5. Bayer MaterialScience Names BioAmber As Its Supplier For New Product Line - Bio-succinic acid forms backbone of innovative new bio-based polyurethanes for textiles
6. BioAmber Inc. Announces Public Offering Of Common Stock
7. BioAmber Inc. Announces Pricing Of $35.1 Million Registered Offering
8. BioAmber Reports First Quarter 2015 Financial Results
9. BioAmber Achieves Important Milestone: Sarnia Construction Substantially Complete
10. BioAmber and DuPont Tate & Lyle Bio Products Partner in Synthetic Leather
11. BioAmber Announces Webcast of Fiscal Second Quarter 2015 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2019)... (PRWEB) , ... September 03, ... ... provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, ... Director, Science & Technology will present at the upcoming Nordic Life Science ...
(Date:8/29/2019)... Kan. (PRWEB) , ... August 28, 2019 , ... ... expertise and wide-ranging DuPont™ Danisco® ingredient solutions to attendees at the International Baking ... to solve today’s baking challenges from optimizing production efficiency to cost and waste ...
(Date:8/27/2019)... ... August 27, 2019 , ... Modality ... announce it has promoted Consulting Engineer, Robert Battista, to Senior Consulting engineer. , ... of onboarding and mentoring new engineers as well as the creation of additional ...
(Date:8/23/2019)... , ... August 22, 2019 , ... ... drug delivery modalities and is scheduled to broadcast 4Q/2019. Check your local listings ... state-of-the-art skin patches for generic drug delivery. Focusing on therapeutics for children and ...
Breaking Biology Technology:
(Date:9/8/2019)... ... September 06, 2019 , ... ... and leading supplier of innovative human mesenchymal stem/stromal cell (hMSC) biomanufacturing systems, ... cord (hUC) MSC paired cell and media system designed for product development. ...
(Date:8/29/2019)... ... August 29, 2019 , ... Advancements with Ted Danson announced ... upcoming episode, which is scheduled to broadcast 1Q/2020. Check local listings for more ... robotic surgical solutions for the treatment of patients suffering from spinal disorders. Traveling ...
(Date:8/27/2019)... FARMINGTON, Conn. (PRWEB) , ... August 26, 2019 , ... ... populations down to the strain level, has hired Bill McKenzie as its CEO and ... are expected to help Shoreline Biome meet growing demand for its products and expand ...
Breaking Biology News(10 mins):